Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.

Authors:
  • DFD B Frewin
    D B Frewin
  • RPR K Penhall
    R K Penhall
  • PLP P Leonello
    P P Leonello
  • RCR J Clapp
    R J Clapp
Google Scholar
  • 26 November 1980
    • journal article
    • Vol. 92  (672) , 389-90
    • PMID:6937768
Abstract
Thirty hypertensive patients treated with a drug regimen which contained a beta-receptor antagonist (either propranolol, pindolol or metoprolol) exhibited an improvement in blood pressure control when atenolol was substituted for the corresponding beta-blocker in the drug regimen. Additional benefits noted were a reduction in concomitant drug therapy and an improvement in reported side effects. Atenolol caused a significant decrease in heart rate in the group for which the mean follow-up period was 23.6 months.